Insiders · Profile

SHARP PHILLIP A

Director at ALNYLAM PHARMACEUTICALS · Director at Biogen. Filing since 8 Apr 2008. CIK 0001226295

Company
Date
Role
Action
Shares
Amount
Of holding
23 Jan 2025
Director
Sold on a plan
11,250
$3.09M
100%
29 Feb 2024
Director
Sold on a plan
30,000
$4.54M
100%
15 Aug 2022
Director
Sold, plan not stated
33,670
$7.76M
100%
9 Feb 2022
Director
Sold, plan not stated
30,000
$4.50M
100%
25 Nov 2020
Director
Sold, plan not stated
30,000
$3.75M
11.3%
12 Feb 2020
Director
Sold, plan not stated
30,000
$3.90M
11.3%
18 Nov 2019
Director
Sold, plan not stated
15,000
$1.38M
6.0%
15 Apr 2019
Director
Sold, plan not stated
15,000
$1.32M
6.0%
13 Mar 2018
Director
Sold, plan not stated
15,000
$2.24M
9.6%
9 Mar 2018
Director
Sold, plan not stated
15,000
$1.94M
9.6%
1 Feb 2017
Director
Sold, plan not stated
25,000
$995.12K
15.1%
25 Jan 2017
Director
Sold, plan not stated
15,000
$569.25K
9.6%
18 Jan 2017
Director
Sold, plan not stated
15,000
$567.46K
9.6%
4 Dec 2015
Director
Sold, plan not stated
30,000
$3.27M
17.6%
13 Oct 2014
Director
Sold, plan not stated
110,000
$9.35M
59.5%
22 Jan 2013
Director
Bought
4,967
$99.99K
53.4%
21 Feb 2012
Director
Bought
9,302
$100.00K
opened
21 Jul 2008
Director
Sold, plan not stated
72,500
$4.93M
13.4%
8 Apr 2008
Director
Sold, plan not stated
100,000
$6.47M
17.7%
19 decisions on file.